Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Biochim Biophys Acta Mol Basis Dis. 2021 Apr 30;1867(8):166162. doi: 10.1016/j.bbadis.2021.166162

Fig. 2. Phosphorylated tau sites kinase dependent regulation.

Fig. 2.

Small molecule for p-tau at Ser 285 and Tyr 310 dual specificity tyrosine-phosphoiylationregulated kinase 1A (DYRK1A) is a new high-potential therapeutic approach for Alzheimer disease. Small molecule inhibits p-tau and DYRK1A-induced Tau phosphorylation by regulating GSK3β, CDK5 including p-tau aggregation.